Hot Features
Premium
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Zeitraum:
Zeichenmodus:
| Volumen | 0 |
|
|||||
| News | - | ||||||
| Tageshoch | Niedrig Hoch |
||||||
| Tagestief | |||||||
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| Acorda Therapeutics Inc | ACOR | NASDAQ | Common Stock |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| 0,00 | 0,00% | 0,661 | 02:00:00 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 0,661 |
| Trades | Volumen | Durchsch. Volumen | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0,6116 - 24,196 |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| - | 0 | US$ 0,661 | USD |
Finanzwerte ACOR
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| US$ 821,03k | - | - | - | -0,38 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Acorda Therapeutics
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 15.4.2024 | 23:03 | Business Wire | Acorda Therapeutics Announces Delisting from Nasdaq |
| 03.4.2024 | 23:30 | Business Wire | Acorda Therapeutics Announces Nasdaq Delisting Notification |
| 02.4.2024 | 00:35 | Business Wire | Acorda Therapeutics and Merz Announce Signing of “Stalking.. |
| 01.4.2024 | 22:01 | Business Wire | Acorda Cancels Q4 and Year End 2023 Earnings Conference Call.. |
| 25.3.2024 | 21:01 | Business Wire | Acorda Fourth Quarter/Year End 2023 Update:.. |
| 11.1.2024 | 14:33 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11.1.2024 | 14:01 | Business Wire | Acorda Therapeutics to Regain Global Commercialization.. |
| 01.12.2023 | 22:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 13.11.2023 | 22:16 | Edgar (US Regulatory) | Form 8-K - Current report |
| 13.11.2023 | 22:01 | Business Wire | Acorda Therapeutics Reports Third Quarter 2023 Financial.. |
| 06.11.2023 | 22:01 | Business Wire | Acorda Third Quarter 2023 Update: Webcast/Conference Call.. |
| 06.11.2023 | 14:00 | Business Wire | Acorda Therapeutics Announces Biopas Laboratories Submission.. |
Forum Acorda Therapeutics
Keine Diskussionen Gefunden.Neuen Thread Erstellen
ACOR Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 1 Monat | 12,40 | 13,74 | 0,6116 | 1,89 | 713.006 | -11,74 | -94,67% |
| 3 Monate | 15,57 | 17,1499 | 0,6116 | 2,08 | 159.508 | -14,91 | -95,75% |
| 6 Monate | 10,01 | 18,00 | 0,6116 | 2,49 | 70.673 | -9,35 | -93,40% |
| 1 Jahr | 9,80 | 24,196 | 0,6116 | 15,04 | 250.763 | -9,14 | -93,26% |
| 3 Jahre | 94,00 | 127,20 | 0,6116 | 27,10 | 718.306 | -93,34 | -99,30% |
| 5 Jahre | 1.364,40 | 1.458,00 | 0,6116 | 145,10 | 1.350.922 | -1.363,74 | -99,95% |
